Apyx Medical price target lowered to $6 from $8 at Craig-Hallum

Craig-Hallum lowered the firm’s price target on Apyx Medical to $6 from $8 and keeps a Buy rating on the shares. Given the in-line results, management felt comfortable narrowing their FY24 revenue guidance ranges, the analyst tells investors in a research note. The capital equipment environment remains challenged, however handpiece utilization provided a nice offset, the firm says.